NHAS
DYN icon

Novo Holdings A/S’s Dyne Therapeutics DYN Stock Holding History

Novo Holdings A/S’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.3M Buy
+960,394
New +$17.9M 1.24% 21

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Novo Holdings A/S's DYN Position: Q2 2026 in Review

Novo Holdings A/S opened a new position in Dyne Therapeutics (DYN) in Q2 2026: 960,394 shares worth $21.3M. The stake represents 1.24% of the portfolio and ranks #21 among its holdings.

246 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Novo Holdings A/S held 960,394 shares of Dyne Therapeutics worth $21.3M as of Q2 2026.
  • Dyne Therapeutics was a new Novo Holdings A/S position in Q2 2026.
  • Dyne Therapeutics made up 1.24% of Novo Holdings A/S's portfolio in Q2 2026, its #21 holding.
  • 246 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Novo Holdings A/S's 13F filing for Q2 2026, filed 14 Aug 2026.